Compare NXDT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NXDT | NAUT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.1M | 218.6M |
| IPO Year | N/A | 2020 |
| Metric | NXDT | NAUT |
|---|---|---|
| Price | $5.47 | $1.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 157.8K | ★ 1.2M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ 0.99 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | $5.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.55 | $0.62 |
| 52 Week High | $5.95 | $4.31 |
| Indicator | NXDT | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 38.80 |
| Support Level | $4.35 | $1.61 |
| Resistance Level | $5.57 | $1.87 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 43.75 | 29.29 |
NexPoint Diversified Real Estate Trust is an externally advised REIT focused on the acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties throughout the United States. The company has two reportable segments: The Diversified reportable segment is focused on investing in various commercial real estate property types and across the capital structure, including but not limited to, equity, mortgage, debt, mezzanine debt and preferred equity. The Hospitality segment is focused on operating and renovating its U.S. located hospitality assets that meet its investment objective and criteria. Its Portfolio includes investments in the single-family rental, self-storage, office, hospitality, life science and multifamily sectors.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.